Business Daily from THE HINDU group of publications
Tuesday, Feb 03, 2009
ePaper | Mobile/PDA Version | Audio | Blogs

News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Corporate - Research & Development
Swiss pharma co Lonza evaluating prospects in India

Our Bureau

Hyderabad, Feb. 2 Lonza, a $2.5 billion Switzerland-based supplier to pharmaceutical, healthcare and life science industries, is evaluating prospects in India for manufacturing and custom manufacturing activities.

“We are in the process of looking for a 20-acre site for the expansion in India. The site will be used to build research capabilities initially in the bioscience area, biopharmaceutical area and microbial control area,” Mr Stefan Borgas, CEO, Lonza, said while addressing a press conference on the sidelines of the BioAsia 2009 meet here.

Second phase

He added that in the second phase they would consider backward integration into manufacturing. The company is exploring at a three to five year project horizon.

“We are looking at several locations including Hyderabad. Another important aspect for the facility is to get skilled biologists and biochemists. Finally the decision will also depend on the type of support that we get from the local Government,” Mr Borgas said.

According to him, the company would invest between $20-50 million over the next three years on creating the research infrastructure.

AVESTHAGEN FACILITY

Avesthagen Ltd in a release issued on Monday said that under its bioNutrition programme, has developed the commercial production of DHA (docosahexaenoic acid) and will be shortly starting a 50 Kilo lts fermentation plant at SP Biotech Park.

It also proposes to set up a Biosimilars facility in a 50-acre BioPharma Park in the Genome Valley with an investment of over Rs 150 crore.

GREENPORT CORPORATION

GreenPort Corporation is looking for financial partners for setting up agro parks in various locations in South and Western parts of the country initially.

“We have a plan to locate land in two places – one near Bangalore and other near Chennai and by March we should finalise the location. Roughly we will require around 5,000 acres and the investment projected is Rs 2,000 crore per park,” Dr RamalingaRaju. S, Head (Livestock Projects), Green Port said here.

The company has entered into a collaboration with Alterra, Wageningen University of Netherlands, to prepare a master plan.

More Stories on : Research & Development | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page




Stories in this Section
Swiss pharma co Lonza evaluating prospects in India


Fall in crude rates: Castrol India cuts prices
Century Textiles cuts output
Books of Educomp, six PSUs come under Govt lens
Market participants welcome SEBI move
Indian CAs can soon practice in Australia
Time to act, not just react
Raymond slips into red on forex losses
Cos recruit 20% more engg students at JK Tyre Baja SAE
RCom to transfer optical fibre biz to Reliance Infratel
CII seeks protection for non-executive directors against criminal liability
Biological E’s new facility in AP inaugurated
5 cos to invest Rs 6,520 cr in Maharashtra
GAIL, IFFCO sign MoU
Oil PSUs agree to spend 2% of profits on social responsibilities
Merck talking to 10 pharma cos for tie-ups
My TVS to expand car service biz to 14 States by year-end
Hyundai raises i20 production
DLF to raise over Rs 2,000 cr thru ‘non-strategic’ assets sale
Maruti bucks trend with highest-ever car sales in Jan
Mahindra sells 1,788 Xylo units in 2 weeks
New MD for Timex


Brandline



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2009, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line